This inventor holds 1 USPTO granted patent. Top assignee: Mayo Foundation for Medical Education and Research. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Jan-Marie Willard Munz: Innovator in Cancer Outcome Prediction
Introduction
Jan-Marie Willard Munz is a notable inventor based in Oronoco, MN (US). He has made significant contributions to the field of cancer research, particularly in assessing prostate cancer outcomes. His innovative work has the potential to improve patient care and treatment strategies.
Latest Patents
Jan-Marie holds a patent related to predicting cancer outcomes. This patent, titled "Predicting Cancer Outcome," provides methods and materials for assessing prostate cancer in mammals. It includes nucleic acids and polypeptides that can be analyzed to determine whether a male mammal with prostate cancer is likely to have a good or poor outcome. This advancement is crucial for tailoring treatment plans to individual patients.
Career Highlights
Jan-Marie is affiliated with the Mayo Foundation for Medical Education and Research, where he applies his expertise in cancer research. His work is instrumental in developing new methodologies that can lead to better prognostic tools for prostate cancer.
Collaborations
Jan-Marie collaborates with esteemed colleagues, including Eric W Klee and Lori S Tillmans. Their combined efforts contribute to the advancement of cancer research and the development of innovative solutions in the medical field.
Conclusion
Jan-Marie Willard Munz is a pioneering inventor whose work in predicting cancer outcomes is making a significant impact in the medical community. His contributions are vital for improving the prognosis and treatment of prostate cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
